DE2517772A1 - Cyclopentanderivate und verfahren zu ihrer herstellung - Google Patents

Cyclopentanderivate und verfahren zu ihrer herstellung

Info

Publication number
DE2517772A1
DE2517772A1 DE19752517772 DE2517772A DE2517772A1 DE 2517772 A1 DE2517772 A1 DE 2517772A1 DE 19752517772 DE19752517772 DE 19752517772 DE 2517772 A DE2517772 A DE 2517772A DE 2517772 A1 DE2517772 A1 DE 2517772A1
Authority
DE
Germany
Prior art keywords
berlin
bank
account
berliner
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19752517772
Other languages
German (de)
English (en)
Inventor
Bernd Dr Raduechel
Werner Dr Skuballa
Helmut Dr Vorbrueggen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE19752517772 priority Critical patent/DE2517772A1/de
Priority to DK142076A priority patent/DK142076A/da
Priority to SE7604410A priority patent/SE7604410L/xx
Priority to LU74764A priority patent/LU74764A1/xx
Priority to CA250,353A priority patent/CA1069504A/en
Priority to NL7604015A priority patent/NL7604015A/xx
Priority to FR7611333A priority patent/FR2307808A1/fr
Priority to BE166253A priority patent/BE840870A/xx
Priority to JP51044408A priority patent/JPS51128957A/ja
Publication of DE2517772A1 publication Critical patent/DE2517772A1/de
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
DE19752517772 1975-04-18 1975-04-18 Cyclopentanderivate und verfahren zu ihrer herstellung Ceased DE2517772A1 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE19752517772 DE2517772A1 (de) 1975-04-18 1975-04-18 Cyclopentanderivate und verfahren zu ihrer herstellung
DK142076A DK142076A (da) 1975-04-18 1976-03-30 Cyklopentanderivater og fremgangsmade til fremstilling deraf
SE7604410A SE7604410L (sv) 1975-04-18 1976-04-14 Cyklopentanderivat och sett att framstella desamma
LU74764A LU74764A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-04-18 1976-04-14
CA250,353A CA1069504A (en) 1975-04-18 1976-04-15 Cyclopentane derivatives and process for their manufacture
NL7604015A NL7604015A (nl) 1975-04-18 1976-04-15 Werkwijze voor het bereiden van cyclopentaan- derivaten, alsmede werkwijze voor het bereiden van 13,14-dihydro-15-methyl-prostaglandine f2ã(alpha) en derivaten daarvan.
FR7611333A FR2307808A1 (fr) 1975-04-18 1976-04-16 Derives de perhydrocyclo-penta(b)furannone-2 utilisables pour la preparation de prostaglandines
BE166253A BE840870A (fr) 1975-04-18 1976-04-16 Derives de cyclopentane et leur procede de preparation
JP51044408A JPS51128957A (en) 1975-04-18 1976-04-19 Cyclopentane derivatives and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752517772 DE2517772A1 (de) 1975-04-18 1975-04-18 Cyclopentanderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DE2517772A1 true DE2517772A1 (de) 1976-10-28

Family

ID=5944670

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752517772 Ceased DE2517772A1 (de) 1975-04-18 1975-04-18 Cyclopentanderivate und verfahren zu ihrer herstellung

Country Status (9)

Country Link
JP (1) JPS51128957A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE840870A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1069504A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2517772A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK142076A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2307808A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU74764A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7604015A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE7604410L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1525891A (en) * 1976-02-02 1978-09-20 Upjohn Co Prostaglandin intermediates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2517771A1 (de) * 1975-04-18 1976-10-28 Schering Ag Neue prostaglandin-acetylen-analoga und verfahren zu ihrer herstellung
GB1525891A (en) * 1976-02-02 1978-09-20 Upjohn Co Prostaglandin intermediates

Also Published As

Publication number Publication date
JPS51128957A (en) 1976-11-10
LU74764A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-01-12
FR2307808A1 (fr) 1976-11-12
DK142076A (da) 1976-10-19
BE840870A (fr) 1976-10-18
SE7604410L (sv) 1976-10-19
NL7604015A (nl) 1976-10-20
CA1069504A (en) 1980-01-08
FR2307808B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-07-13

Similar Documents

Publication Publication Date Title
DE2652256C2 (de) Polyprenylalkohole und diese enthaltende pharmazeutische Zusammensetzungen
CH651292A5 (de) Bicyclo(3,3,0)octan-derivate.
DE2437388A1 (de) Prostansaeurederivate
DE2356383A1 (de) Chemische zwischenprodukte, die sich zur herstellung von prostaglandinen und prostaglandinartigen verbindungen eignen
DE2223365C3 (de) Prostansäurederivate, Verfahren zu ihrer Herstellung, solche Derivate enthaltende pharmazeutische und veterinäre Zusammensetzungen sowie Zwischenprodukte zur Herstellung dieser Derivate
DE2255167C2 (de) Verfahren zur Trennung einer α-(verätherten Oximino)-carbonsäure in die syn- und anti-Bestandteile
DE1803157A1 (de) Verfahren zur Herstellung von polycyclischen Verbindungen
DE2330333C2 (de) 9-Desoxy-prosta-5,9(10),13-triensäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutischen Zubereitungen
DE2315355A1 (de) Verfahren zur herstellung von oximen
DE2610503C2 (de) Optisch aktive 13,14-Dehydro-11- desoxy-prostaglandine, Verfahren zu ihrer Herstellung und sie enthaltendes pharmazeutisches Mittel
DE2539116C2 (de) ω-Nor-cycloalkyl-13,14-dehydro-prostaglandine, Verfahren zu ihrer Herstellung sowie sie enthaltende pharmazeutische Mittel
DE2517772A1 (de) Cyclopentanderivate und verfahren zu ihrer herstellung
DE2743283A1 (de) Neue prostacyclin-analoga
DE2502919C2 (de) Cyclopentan-Derivate, Verfahren zu ihrer Herstellung, sowie diese enthaltende pharmazeutische Zusammensetzungen
DE2601646C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE2323454A1 (de) Verfahren zur herstellung von cyclopentenverbindungen
CH617424A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE68909143T2 (de) Prostaglandin-Vorläufer und ihre Herstellung.
CH628639A5 (en) Process for the preparation of furanose derivatives
DE2626288C2 (de) Verfahren zur Herstellung von Prostaglandinzwischenprodukten durch stereoselektive Reduktion
DE2331997A1 (de) Verfahren zur herstellung von bicycloalkan-derivaten
DE2655004C3 (de) Verfahren zur Herstellung von bicyclischen Laktonen
DE2209039A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE2733976A1 (de) Neue cyanprostaglandine und verfahren zu deren herstellung
EP0113311B1 (de) 5-Fluorcarbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8131 Rejection